3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Motor Activity
126
Breast Neoplasms
78
Neoplasms
48
Prostatic Neoplasms
19
Fatigue
16
Obesity
14
Colorectal Neoplasms
13
Lung Neoplasms
11
Polycystic Ovary Syndrome
10
Colonic Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Head and Neck Neoplasms
7
Weight Loss
6
Ovarian Neoplasms
6
Rectal Neoplasms
5
Multiple Myeloma
5
Lymphedema
5
Leukemia
5
Inflammation
5
Pancreatic Neoplasms
4
Overweight
4
Multiple Endocrine Neoplasia Type 1
4
Lymphoma
4
Leukemia, Myeloid, Acute
4
Insulin Resistance
4
Depression
4
Cognitive Dysfunction
4
Brain Neoplasms
4
Stomach Neoplasms
3
Peripheral Nervous System Diseases
3
Interventions
relacorilant
4
Resistance Training
3
Pioglitazone
3
Dipeptidyl-Peptidase IV Inhibitors
3
Sulfonylurea Compounds
2
Rosiglitazone
2
Nutritional Status
2
Metformin
2
voglibose
1
saxagliptin
1
repaglinide
1
pembrolizumab
1
miglitol
1
metahexamide
1
meglitinide
1
glymidine
1
glisoxepide
1
gliquidone
1
glimepiride
1
glibornuride
1
empagliflozin
1
Vildagliptin
1
Troglitazone
1
Tolbutamide
1
Tolazamide
1
Thiazolidinediones
1
Surveys and Questionnaires
1
Sodium-Glucose Transporter 2 Inhibitors
1
Sitagliptin Phosphate
1
Resistant Starch
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Diabetes Mellitus, Type 2
×
Exercise
×
Clear all
NCT00786019
2023-07-12
InsITE
University of Colorado, Denver
Phase NA
Completed
47 enrolled
22 charts